Lynn Scott’s clients go to her for practical and business-centric legal advice. Lynn is a member of Polsinelli’s Technology Transactions & Data Privacy Group and is Co-Chair of the Health Care Technology & Innovation Practice. She combines industry-specific knowledge with cutting edge and innovative solutions to help clients address challenges and take advantage of opportunities. She represents clients in a variety of sectors, including: 
  • Health care
  • Health care technology 
  • Technology
  • Life sciences
  • Startup ventures
  • Venture capital
With over 20 years of law firm and in-house hands-on experience, Lynn routinely advises clients on:
  • Licensing and commercialization of intellectual property 
  • Data use, aggregation, monetization and commercialization
  • Commercial contractual issues (technology, health care, IT, and telecommunications related agreements and government contracts) 
  • Capital raising activities, including institutional and strategic venture capital and private equity investments 
  • Joint Ventures, mergers and acquisitions 
  • Research and development activities 
She advises corporate entities, academic institutions, medical centers and hospital systems regarding data aggregation, usage and monetization, licensing, sponsored research and development and other activities related to internally developed intellectual property. Lynn has experience with the technology and contractual aspects of HIEs and the provision of telehealth services.

She also advises pharma/biotechnology clients with various research and development activities and clinical trial related agreements for precision medicine and drugs and medical devices, including sponsor, supply and quality agreements. In addition, she works with her IP colleagues with respect to software and other technology and telecommunications related agreements.
 
Lynn is a frequent speaker at conferences and webinars on blockchain technology, smart contracts, artificial intelligence, data use aggregation, licensing and protection.
  • Represented corporate entities and academic institutions regarding data use agreements.
  • Represented a state entity in the formation of a statewide health information exchange.
  • Represented a chemical synthesis company in its license and option agreement with a public pharmaceutical company.
  • Represented a large health care technology company in contractual and acquisition related matters.
  • Represented a pharmaceutical company in a merger transaction.
  • Represented a research organization in licensing and corporate matters.
  • Represented a clinical regulatory company in a merger transaction.
  • Represented a development company in venture capital transactions.